Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Adults using a GLP-1 had an increase in GFR from 50.48 mL/min/1.73 m 2 at baseline to 53.44 mL/min/1.73 m 2 at 6 months, whereas the control group had a decrease from 43.4 mL/min/1.73 m 2 at baseline to 40.84 mL/min/1.73 m 2 at 6 months ( P = .03)
Front Neurol 12:661740 Kara M, Trkn H, Karaca T, Gl O, Uysal S, Trkylmaz M, Demirta S, Dereky FS (2016) Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model
Figure 1: The increase in type 2DM and cardiovascular death
P.HellerR
A post-hoc analysis of selected safety outcomes showed increased odds of hypoglycemic events in propensity score-matched GLP1-RA users compared to DPP4i users (10.3% vs 9.3%, respectively
US$ 29.06
US$ 23.07
US$ 24.62
US$ 22.15
US$ 23.41
